IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 140
Titolo Data di pubblicazione Autore(i) File
The Role of Pemetrexed in the Pharmacotherapy of Malignant Pleural Mesothelioma 1-gen-2010 Zucali, P.; De Vincenzo, F.; Simonelli, M.; Lorenzi, E.; Perrino, M.; Santoro, A.
Expression of the transcription factor HEY1 in glioblastoma: a preliminary clinical study 1-gen-2010 Gaetani, P; Hulleman, E; Levi, D; Quarto, M; Scorsetti, M; Helins, K; Simonelli, M; Colombo, P; Baena, y Rodriguez R
Phase I study of NGR-hTNF administered at high doses in refractory patients with solid tumors 1-gen-2010 Simonelli, M; Santoro, A; Zucali, Pa; Rimassa, L; De Vincenzo, F; Pressiani, T; Tronconi, Mc; Carnaghi, C; Lambiase, A; Bordignon, C
Phase II Study of Asparagine-Glycine-Arginine-Human Tumor Necrosis Factor alpha, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma 1-gen-2010 Gregorc, V; Zucali, PAOLO ANDREA; Santoro, A; Ceresoli, G L; Citterio, G; De Pas T, M.; Zilembo, N; De Vincenzo, F; Simonelli, M; Rossoni, G; Spreafico, A; Vigano, M G; Fontana, F; De Braud, F G; Bajetta, E; Caligaris-Cappio, F; Bruzzi, P; Lambiase, A; Bordignon, C
Retreatment with pemetrexed-based chemotherapy (PBC) in patients with malignant pleural mesothelioma (MPM): An observational study 1-gen-2010 De Vincenzo, F; Zucali, P; Ceresoli, G; Gianoncelli, L; Lorenzi, E; Simonelli, M; Ripa, C; Giordano, L; Santoro, A
VINORELBINE (V) IN PEMETREXED-PRETREATED PATIENTS (PTS) WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM) 1-gen-2010 De Vincenzo, F; Lorenzi, E; Zucali, Pa; Simonelli, M; Gianoncelli, L; Ceresoli, Gl; Ripa, C; Giordano, L; Santoro, A
Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy 1-gen-2010 Prognostic Factors Study Group, International; Simonelli, M; Zucali, P; Lorch, Anja; Beyer, Jörg; Bascoul-Mollevi, Caroline; Kramar, Andrew; H Einhorn, Lawrence; Necchi, Andrea; Massard, Christophe; De Giorgi, Ugo; Fléchon, Aude; A Margolin, Kim; Lotz, Jean-Pierre; Ramon Germa Lluch, Jose; Powles, Thomas; K Kollmannsberger, Christian
Phase I, pharmacokinetics, pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors 1-gen-2011 Simonelli, M; Zucali, Pa; De Sanctis, R; Lorenzi, E; De Vincenzo, F; Rimassa, L; Tronconi, Mc; Personeni, N; Masci, G; Zuradelli, M; Giordano, L; Santoro, A
PHASE II STUDY OF THE COMBINATION OF BEVACIZUMAB PLUS PEMETREXED AND CARBOPLATIN AS FIRST-LINE THERAPY IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM) 1-gen-2011 Ceresoli, Gl; Zucali, Pa; Favaretto, Ag; De Vincenzo, F; Mencoboni, M; Botta, M; Grossi, F; Bidoli, P; Zilembo, N; Simonelli, M; Gianoncelli, L; Lorenzi, E; Santoro, A
NGR-hTNF in previously treated patients with malignant pleural mesothelioma (MPM) 1-gen-2011 De Vincenzo, F; Rossoni, G; Santoro, A; Gregorc, V; Zucali, Pa; Citterio, G; Simonelli, M; Petrella, G; Caligaris-Cappio, F; Lambiase, A; Bordignon, C
Phase I, Pharmacokinetics (PK), Pharmacodynamic (PD) Study of Lapatinib (L) in Combination With Sorafenib (S) in Patients With Advanced Refractory Solid Tumours 1-gen-2011 Simonelli, M; Zucali, Pa; De Sanctis, R; Lorenzi, E; De Vincenzo, F; Rimassa, L; Tronconi, Mg; Zuradelli, M; Giordano, L; Santoro, A
Advances in the biology of malignant pleural mesothelioma 1-gen-2011 Zucali, Pa; Ceresoli, Gl; De Vincenzo, F; Simonelli, M; Lorenzi, E; Gianoncelli, L; Santoro, A
Phase I and pharmacodynamic study of high-dose NGR-hTNF in patients with solid tumors 1-gen-2011 Zucali, Pa; Simonelli, M; De Vincenzo, F; Lorenzi, E; Rimassa, L; Balzarini, L; Quagliuolo, V; Lambiase, A; Bordignon, C; Santoro, A
Treatment of malignant pleural mesothelioma: current status and future directions 1-gen-2011 Zucali, Pa; De Sanctis, R; De Vincenzo, F; Simonelli, M; Lorenzi, E; Perrino, M; Santoro, A
Response to Sunitinib in an Adult Patient With Rhabdoid Renal Cell Carcinoma 1-gen-2011 De Vincenzo, F; Zucali, PAOLO ANDREA; Ceresoli, G L; Colombo, P; Simonelli, M; Lorenzi, E; Perrino, M; Gianoncelli, L; De Sanctis, R; Graziotti, P; Santoro, A; DE SANCTIS, Rita
Phase I, pharmacokinetic (PK), pharmacodynamic (PD) study of lapatinib (L) in combination with sorafenib (S) in patients with advanced refractory solid tumors 1-gen-2011 Simonelli, M; Zucali, Pa; De Sanctis, R; Lorenzi, E; De Vincenzo, F; Rimassa, L; Tronconi, Mc; Personeni, N; Masci, G; Zuradelli, M; Perrino, M; Bertossi, M; Giordano, L; Santoro, A
Thymidylate Synthase and Excision Repair Cross-Complementing Group-1 as Predictors of Responsiveness in Mesothelioma Patients Treated with Pemetrexed/Carboplatin 1-gen-2011 Zucali, PAOLO ANDREA; Giovannetti, E; Destro, A; Mencoboni, M; Ceresoli, G L; Gianoncelli, L; Lorenzi, E; De Vincenzo, F; Simonelli, M; Perrino, M; Bruzzone, A; Thunnissen, E; Tunesi, G; Giordano, L; Roncalli, M; Peters, G J; Santoro, A
Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma 1-gen-2011 Ceresoli G, L.; Zucali P, A.; De Vincenzo, F; Gianoncelli, L; Simonelli, M; Lorenzi, E; Ripa, C; Giordano, L; Santoro, A
Safety and efficacy of MET inhibitor tivantinib (ARQ 197) combined with sorafenib in patients (pts) with hepatocellular carcinoma (HCC) from a phase I study 1-gen-2012 Martell, Re; Puzanov, I; Ma, Ww; Santoro, A; Dy, Gk; Goff, Lw; Fetterly, Gj; Michael, Sa; Means-Powell, Ja; Chai, F; Lamar, M; Simonelli, M; Chiang, Wm; Jarboe, J; Schwartz, Be; Adjei, Aa
IMPACT OF SOLUBLE TUMOR NECROSIS FACTOR-RECEPTORS (STNF-RS) SHEDDING ON OUTCOME IN PATIENTS TREATED WITH NGR-HTNF 1-gen-2012 Zucali, Pa; Simonelli, M; De Vincenzo, F; Lorenzi, E; Santoro, A; Lambiase, A; Bordignon, C
Mostrati risultati da 21 a 40 di 140
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile